05/10/2024
3:35 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
7:12 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
04/29/2024
3:43 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form DEFA14A | |
04/29/2024
3:45 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form ARS | |
04/19/2024
4:28 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form PRE 14A | |
04/17/2024
3:23 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2024
3:18 PM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
|
03/08/2024
4:20 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/08/2024
7:21 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/16/2024
3:31 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 424B3 | |
02/14/2024
5:32 PM | Jhaveri Nirav S. (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
02/14/2024
5:35 PM | Jayagopal Ashwath (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:37 PM | Jhaveri Nirav S. (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/14/2024
5:29 PM | Jayagopal Ashwath (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
01/23/2024
11:15 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form EFFECT | |
01/22/2024
5:01 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Zaremba Rabourn Amy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/22/2024
5:01 PM | Hoffmann Bernhard (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/11/2024
3:16 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
01/10/2024
4:00 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form S-3
Registration statement under Securities Act of 1933 | |
01/03/2024
4:57 PM | Benton Susan (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
3:30 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Patel Ronil A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
5:19 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
SCHACHLE JOSEPH K (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
11/27/2023
5:24 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
SCHACHLE JOSEPH K (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/27/2023
7:45 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
4:42 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Rodgers Richard J (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:46 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Pepose Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
7:48 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
11/13/2023
7:12 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/03/2023
8:22 AM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
11/03/2023
8:29 AM | Magrath George (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2023
7:44 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/01/2023
3:21 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/27/2023
7:45 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/14/2023
7:00 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 424B5 | |
08/11/2023
8:27 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/11/2023
7:51 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2023
10:21 AM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/14/2023
3:31 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/08/2023
5:48 PM | Gallagher Cam (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:48 PM | Benton Susan (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:49 PM | Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
Pepose Jay (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Biden Nomination CANCELED? (Ad) The Hill just published that Joe Biden has received enough delegates to…“clinch the Democratic presidential nomination and all but guaranteeing he will face off against former President Trump again in November.”
Why is he all BUT guaranteed the Democratic nomination, in their words? I believe I have the terrifying answer right here. |
06/08/2023
5:49 PM | MANUSO JAMES S J (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/08/2023
5:49 PM | Ainsworth Sean (Reporting)
Ocuphire Pharma, Inc. (Issuer)
Ocuphire Pharma (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/02/2023
3:30 PM | Ocuphire Pharma, Inc. (Filer)
Ocuphire Pharma (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
